AMED NAPOLES GARCIA: Open Payments
NPI 1821700063 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,584 in 70 payments from 15 companies in 2025. Trend: 2023 $322 · 2024 $2,067 · 2025 $1,584
Food & beverage: $1,584
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $200 |
| Axsome Therapeutics, Inc. | 8 | $172 |
| Janssen Pharmaceuticals, Inc | 6 | $152 |
| Vanda Pharmaceuticals Inc. | 5 | $146 |
| Alkermes, Inc. | 6 | $129 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Indivior Inc. | 4 | $110 |
| ABBVIE INC. | 4 | $99 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
Products named: INGREZZA, CAPLYTA, Auvelity, SPRAVATO, HETLIOZ, REXULTI, SUBLOCADE, VRAYLAR.
Industry payments across FL — which companies pay providers there.
